14 Facts About Mobileye

Mobileye is a company developing autonomous driving technologies and advanced driver-assistance systems including cameras, computer chips and software.

Mobileye is based in Jerusalem, Israel, and has sales and marketing offices in Midtown, Manhattan, US; Shanghai, China; Tokyo, Japan, and Dusseldorf, Germany.

Mobileye was founded in 1999 by Hebrew University professor Amnon Shashua when he evolved his academic research into a vision system which could detect vehicles using a camera and software algorithms on a processor.

Mobileye established its first research center in 2004, and launched the first generation EyeQ1 processor four years later, in 2008.

Mobileye went public on the New York Stock Exchange in 2014.

Related searches

In 2017, Mobileye unveiled a mathematical model for safe self-driving cars based on a research paper by CEO Amnon Shashua and VP of Technology Shai Shalev-Shwartz.

Mobileye began “robotaxi” trials with NIO electric vehicles in Israel in May 2020 due to a delay in the arrival of Volkswagen minivans, and unveiled its new production-ready robotaxi in 2021 at the IAA Mobility show in Munich.

Mobileye demonstrated an autonomous car equipped only with cameras on the streets of Jerusalem in January 2020, later testing the cars in Munich and New York City.

Mobileye launched multiple series productions for LDW on GM Cadillac STS and DTS vehicles, and on BMW 5 and 6 Series vehicles.

In early 2017, Mobileye announced a partnership with BMW to integrate Mobileye technology into vehicles going to market in 2018.

In 2018, Mobileye announced partnerships with BMW, Nissan and Volkswagen.

Also in 2020, Mobileye announced a partnership with WILLER29 to launch a robotaxi service in Japan, Taiwan and Southeast Asia and with Geely for ADAS.

Mobileye issued a statement that its systems were not designed to recognize a “lateral turn across path” and would not have those capabilities until 2018.

Mobileye Drive was first fitted to vehicles used for driverless, ride-hailing services in 2021, with plans for public testing in Germany and Israel in 2022.